Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biotechnology industry, is capturing the attention of investors with its promising drug pipeline and a significant potential upside of 58.63%...
Neuropace, Inc. (NASDAQ: NPCE), a key player in the healthcare sector, specifically within the medical devices industry, is catching investor attention with a compelling potential upside of 45.50%. Headquartered in..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is currently making waves in the biotechnology industry. With a robust market capitalization of $1.52 billion,..
Investors with an eye on Cronos Group Inc. (NASDAQ: CRON) are witnessing an intriguing narrative unfold in the burgeoning cannabis sector. As a key player in the healthcare industry, specifically..
Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices industry, has been capturing investor attention with its promising potential upside of 34.04%. Headquartered in Burlington, Massachusetts, the..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector with its promising outlook for investors. With a market capitalization of $1.52 billion, Iovance is positioned at the..
Evolus, Inc. (NASDAQ: EOLS) is a name that might not instantly ring a bell for every investor, yet it has carved a niche for itself within the vibrant healthcare sector,..
Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical devices sector, offers investors a unique blend of opportunities and challenges. With a market capitalization of $644.13 million, this..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company rooted in the heart of San Diego, California, is capturing the attention of investors with its robust pipeline and impressive growth metrics...
Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, has captured investor attention with a striking potential upside of 161.44%. This clinical-stage biopharmaceutical company is on an..
RxSight, Inc. (NASDAQ: RXST), a pioneering medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery, finds itself at a crucial juncture. With a current market capitalization..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention as it targets rare respiratory diseases. With a market capitalization of $1.07 billion, the company is focused on..
For investors with an eye on the biotechnology sector, Bicycle Therapeutics plc (NASDAQ: BCYC) presents an intriguing opportunity. With a market capitalization of $313.68 million and a substantial potential upside..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a San Diego-based biotechnology company, is capturing investor attention with a notable potential upside of 40.24%, as suggested by its current analyst ratings. Despite..
For investors seeking a high-risk, high-reward opportunity within the biotechnology sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) presents a compelling case. This innovative company, headquartered in Solana Beach, California, focuses on..
InMode Ltd. (NASDAQ: INMD), an innovative player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a notable 23.64% potential upside, according to analyst targets...
Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is capturing investor attention with its promising potential upside of 67.65%. Specializing in therapies for rare bradykinin-mediated diseases, Pharvaris is advancing its late-stage..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing investor attention with a potential upside of 100.05%, as highlighted by recent analyst ratings. This Chicago-based biopharmaceutical company is dedicated to advancing..
Beta Bionics, Inc. (BBNX) is making waves in the healthcare sector, specifically within the medical devices industry. Headquartered in Irvine, California, this innovative company has gained attention for its cutting-edge..
